Healthequity (NASDAQ:HQY) Given Buy Rating at Cantor Fitzgerald

Healthequity (NASDAQ:HQY)‘s stock had its “buy” rating reiterated by Cantor Fitzgerald in a research note issued to investors on Wednesday, TipRanks reports. They currently have a $95.00 price objective on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 55.13% from the stock’s current price.

A number of other research firms have also issued reports on HQY. Raymond James raised Healthequity from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $90.00 to $80.00 in a report on Monday, September 9th. Deutsche Bank assumed coverage on Healthequity in a report on Thursday, September 12th. They set a “buy” rating and a $74.00 price target for the company. Wells Fargo & Co reduced their price objective on Healthequity from $80.00 to $76.00 and set an “outperformer” rating for the company in a research report on Wednesday, September 4th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research report on Wednesday, November 6th. Finally, TheStreet downgraded shares of Healthequity from a “b” rating to a “c+” rating in a research note on Tuesday, September 3rd. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. Healthequity has a consensus rating of “Buy” and a consensus price target of $77.86.

Healthequity stock opened at $61.24 on Wednesday. The firm has a market cap of $4.44 billion, a price-to-earnings ratio of 64.46, a P/E/G ratio of 2.87 and a beta of 1.47. The company has a debt-to-equity ratio of 0.04, a current ratio of 22.98 and a quick ratio of 22.98. Healthequity has a fifty-two week low of $50.29 and a fifty-two week high of $91.19. The firm has a fifty day moving average price of $59.78 and a two-hundred day moving average price of $64.21.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, December 3rd. The company reported $0.47 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.33. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. The company had revenue of $157.12 million for the quarter, compared to the consensus estimate of $152.38 million. During the same period last year, the business posted $0.25 earnings per share. The firm’s revenue was up 122.9% compared to the same quarter last year. As a group, sell-side analysts expect that Healthequity will post 0.87 earnings per share for the current year.

In other news, CFO Darcy G. Mott sold 4,000 shares of the stock in a transaction on Monday, October 21st. The shares were sold at an average price of $56.90, for a total value of $227,600.00. Following the completion of the transaction, the chief financial officer now owns 42,000 shares in the company, valued at approximately $2,389,800. The sale was disclosed in a filing with the SEC, which is available at this link. Over the last ninety days, insiders sold 12,000 shares of company stock valued at $715,600. 3.70% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. Metropolitan Life Insurance Co NY raised its holdings in shares of Healthequity by 27.1% in the 3rd quarter. Metropolitan Life Insurance Co NY now owns 40,209 shares of the company’s stock worth $2,298,000 after buying an additional 8,567 shares in the last quarter. Millennium Management LLC lifted its position in shares of Healthequity by 84.3% during the 3rd quarter. Millennium Management LLC now owns 261,859 shares of the company’s stock worth $14,963,000 after buying an additional 119,758 shares during the period. Squarepoint Ops LLC boosted its stake in Healthequity by 11.4% in the 3rd quarter. Squarepoint Ops LLC now owns 51,478 shares of the company’s stock valued at $2,942,000 after buying an additional 5,285 shares in the last quarter. Granahan Investment Management Inc. MA boosted its stake in Healthequity by 29.7% in the 3rd quarter. Granahan Investment Management Inc. MA now owns 602,767 shares of the company’s stock valued at $34,445,000 after buying an additional 138,045 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in Healthequity by 13.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 103,556 shares of the company’s stock valued at $5,918,000 after buying an additional 12,132 shares in the last quarter. 95.84% of the stock is currently owned by institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: Portfolio Manager

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.